Sexual Dysfunction significantly associated with women having type1 Diabetes
Sexual dysfunction (SD) in women with diabetes is a complex problem influenced by hormonal, neuropathic, and psychosocial factors. Recent research suggests that the prevalence of SD is higher in women with type 1 diabetes compared to those with type 2 diabetes or without diabetes altogether. The findings of the study were published in Diabetic Medicine Journal.
To shed light on this issue, a systematic review of the literature was conducted. Researchers searched four major electronic databases to identify studies assessing SD in premenopausal women with type 1 diabetes. The initial search, conducted between March 15th and April 29th, 2022, yielded a total of 1,104 articles. After eligibility assessment, 11 studies were included in a meta-analysis.
The findings of the meta-analysis revealed that women with type 1 diabetes are three times more likely to experience SD compared to women without diabetes (odds ratio = 3.8, 95% confidence interval 1.8-8.0, p<0.001). The most commonly used tool for measuring SD was the Female Sexual Function Index (FSFI), and in three studies, it was combined with the Female Sexual Distress Scale (FSDS). Additionally, several factors showed a significant association with SD, including depression, anxiety, and the duration of diabetes.
This review underscores the significant issue of SD in women with type 1 diabetes. The higher prevalence rates highlight the need for increased attention from diabetes professionals and policymakers. Incorporating female SD (FSD) into care pathways and clinical guidelines can help address this overlooked aspect of diabetes management.
The implications of this study extend beyond the medical realm. Sexual well-being is a vital aspect of overall quality of life, and addressing SD in women with type 1 diabetes can have positive effects on mental health and relationship satisfaction. By recognizing the multifaceted nature of SD and considering the various factors involved, healthcare providers can provide comprehensive care and support to women affected by this complication.
Additionally, interventions targeting psychosocial factors such as depression and anxiety may prove beneficial in alleviating SD symptoms. By prioritizing this issue, healthcare professionals can improve the overall well-being and quality of life for women living with type 1 diabetes.
Source:
Hashim, R., Forde, R., Ausili, D., & Forbes, A. (2023). Prevalence and associated factors of sexual dysfunction in premenopausal women with type 1 diabetes: A systematic review and meta‐analysis. In Diabetic Medicine. Wiley. https://doi.org/10.1111/dme.15173
